Cargando…
Anticancer effect of (S)-crizotinib on osteosarcoma cells by targeting MTH1 and activating reactive oxygen species
MTH1 has become a new rising star in the field of ‘cancer phenotypic lethality’ and can be targeted in many kinds of tumors. This study aimed to explore the anticancer effect of MTH1-targeted drug (S)-crizotinib on osteosarcoma (OS) cells. We detected MTH1 expression in OS tissues and cells using im...
Autores principales: | Qing, Xiangcheng, Shao, Zengwu, Lv, Xiao, Pu, Feifei, Gao, Feng, Liu, Lei, Shi, Deyao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882294/ https://www.ncbi.nlm.nih.gov/pubmed/29420337 http://dx.doi.org/10.1097/CAD.0000000000000602 |
Ejemplares similares
-
Stereospecific targeting of MTH1 by (S)-crizotinib as anticancer strategy
por: Huber, Kilian V. M., et al.
Publicado: (2014) -
Contribution of reactive oxygen species to the anticancer activity of aminoalkanol derivatives of xanthone
por: Sypniewski, Daniel, et al.
Publicado: (2017) -
Reactive Oxygen Species Regulate Endoplasmic Reticulum Stress and ER-Mitochondrial Ca(2+) Crosstalk to Promote Programmed Necrosis of Rat Nucleus Pulposus Cells under Compression
por: Lin, Hui, et al.
Publicado: (2021) -
MTH1 inhibitor amplifies the lethality of reactive oxygen species to tumor in photodynamic therapy
por: Zhao, Lingzhi, et al.
Publicado: (2020) -
TIM-3 expression and its association with overall survival in primary osteosarcoma
por: Pu, Feifei, et al.
Publicado: (2019)